A key challenge in chemical biology is to identify small molecule regulators for every single protein. However, protein surfaces are notoriously difficult to recognise with synthetic molecules, often having large flat surfaces that are poorly matched to traditional small molecules. In the surface mimetic approach, a supramolecular scaffold is used to project recognition groups in such a manner as to make multivalent non-covalent contacts over a large area of protein surface. Metal based supramolecular scaffolds offer unique advantages over conventional organic molecules for protein binding, inlcuding greater steroechemcial and geometrical diversity conferred through the metal centre and the potential for direct assessment of binding properties and even visualisation in cells without recourse to further functionalisation. This feature article will highlight the current state of the art in protein surface recognition using metal complexes as surface mimetics.
Introduction
The last decade has seen an increasing diversity of new methods to target protein function 1,2 including control of protein localisation, 3 and degradation. 4, 5 The prevailing methods, however, still centre on development of ligands which prevent the protein of interest from engaging in interactions with substrates (e.g. small molecules or other proteins), through either an orthosteric or allosteric mode of action. Whilst methodologies to identify suitable chemical matter for established protein targets such as GPCRs and enzymes are well known, 6 the difficulty in achieving the goal of a 7 has been most acutely demonstrated through efforts to identify inhibitors of protein-protein interactions (PPIs). 8 10 Supramolecular Chemical Biology 8 can offer solutions to this challenge: the surface mimetic approach involves the recognition of large areas of a protein surface, using a functionalized supramolecular scaffold capable of making multivalent non-covalent contacts to achieve strong and selective binding (Fig. 1) . 11 Multivalency is widely exploited in nature, permitting an increased binding affinity by increasing the number of ligands and receptor sites, for example in signal transduction, cell membrane adherence, and immunological responses. A recent review by Ulrich et al. has outlined how multivalency can be used to inhibit enzymes. 12 Figure 1 General schematic of the surface mimetic approach, a large multivalent, supramolecular molecule binds to a protein surface, potentially disp lacing a natural protein binding partner This feature article will highlight the development of the surface mimetic approach 13, 14 to protein surface T surface mimetic 15, 16 which refers to small molecules mimicking a region of protein structure (usually a -helix or -sheet). The initial section of the article will focus on organic supramolecular scaffolds to illustrate the thinking in developing this approach, before moving on to metal co-ordination complex scaffolds as ligands for protein surfaces.
Metal complexes have had a huge impact on medicinal chemistry starting with the introduction of cisplatin. The discovery and development of cytotoxic organometallic small molecules and co-ordination complexes has been reviewed on numerous occasions previously. 17 20 Similarly, the use of co-ordination complexes as ligands for nucleic acids has seen extensive development and the reader is directed towards recent review articles. 21, 22 In contrast metal complexes for protein-surface recognition are less well developed, however, metals offer distinct advantages for this challenging goal over conventional organic scaffolds (Fig  2. ). Advantages of metal complexes include the ability to offer a variety of co-ordination numbers and geometries ( Fig. 2) , thus expanding the number of globular shapes available and allowing exploration of protein pockets and surfaces inaccessible to conventional small organic molecules. 23 Metal complexes also have the ability to exist in many more stereoisomers than organic molecules, for example an sp 3 carbon with 4 different substituents has only two possible stereoisomers whereas an octahedral metal centre with 6 different ligands can exist in up to 30 different stereoisomers (Fig.  2) . 19 Critically, protein binding selectivity of small molecules has been shown to correlate with both shape and stereochemical complexity, 24 emphasizing how the diversity of metal complex ligands might be used for selective protein recognition. The use of metal complexes allows for combinatorial synthesis in order to generate a wide range of metal complexes using similar reactions, 19 thus permitting a variety of compounds to be screened readily. The metal centre itself can be used solely as a scaffold, for forming coordinative bonds with the biological macromolecule, and for its reactive capacity, thus expanding the scope of interactions possible to achieve binding. 19 In addition, the ligands on the metal play a role in the redox behaviour, biostability, absorption and delivery of the metal complex, and can be used to direct the synthesis towards particular stereoisomers (e.g. using the trans effect). Moreover, use of metal complexes provides direct entry to molecular sensors. Through judicious choice of metal scaffold, intrinsic luminescence can detect molecular recognition and cellular behaviour, e.g. ruthenium(II) and iridium(III) complexes are phosphorescent, allowing direct visualisation in both biological assays and cellular imaging. 25 In contrast, most traditional organic ligands need derivatization, often through lengthy syntheses, which result in changes to (molecular recognition and physicochemical) properties. Finally, although our own driver for this work has been to address deficiencies in the ability to identify inhibitors of protein-protein interactions, the exploitation of metal complexes for protein surface recognition has had influence more widely e.g. in developing kinase inhibitors with superior selectivity profiles. 19 
Calixarenes
Calixarenes are cone-like molecules with two distinct edges that can be functionalised with recognition elements for protein surface recognition. 27 Their biological use has been recently reviewed by Nimse and Kim. 27 The Hamilton group introduced the concept of protein-surface mimetics recognizing the potential of calix [4] arene derivatives for this purpose (Fig. 3a) . 28 A series of derivatives were identified that bind to cytochrome (Cyt) c -chymotrypsin and platelet-derived growth factor (PDGF), acting as antibody mimics. 14,28 30 Most impressively, GFB-111, a PDGF binder with IC50 ~ 250 nM was shown to inhibit tumour growth and angiogenesis in vivo. 30 More recently, Crowley and coworkers, have highlighted an active role for these scaffolds, 31 solving crystal structures of a psulfonatocalix [4] arene bound to Cyt c (Fig. 3b) 32 and lysozyme. 33 In the former, binding occurred at three different sites, with the calixarenes acting as mediators of the PPIs required for crystallisation. 31 Please do not adjust margins Please do not adjust margins assays/sensors for antibody free detection of histone modifications through lysine side chain recognition. 35, 36 
Porphyrins
Since 1950, porphyrins have been used for proteinsurface recognition, initially focussed on binding to human serum albumin, 37 39 but since then, many other targets including Kv potassium channels, 40 44 VEGF, 45 Cyt c 46, 47 and lectins 48 50 have been studied. Hamilton and co-workers recognised the potential of functionalized porphyrin ligands as bona fide receptors for proteinsurface recognition, developing potent ligands for Cyt c. 46, 51 These studies are discussed in greater detail later in this article.
Trauner and coworkers rationally designed a tetraphenylporphyrin-based scaffold (Fig. 4a) which targets the Kv potassium channel with nanomolar affinity, and reduces the current through the channel. 41 The C4 symmetry of the porphyrin was thought to be well-suited to the tetrameric nature of the potassium channel. 41 However it has since been shown, by solid state NMR, that the porphyrin lies perpendicular to the protein, projecting one of its cationic side chains into the channel. 40, 52 The porphyrin blocks the ion conduction pathway and stabilises a closed Kv channel state upon interaction with the voltage sensor domain. 44 Further studies have been directed towards inhibiting specific Kv1 channels. 53 The Yayon group studied porphyrins that bind to fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF), 45 a protein important in tumour angiogenesis and metastasis, 54 with low micromolar affinity in vitro, in cellulo, and in vivo (mouse). They also showed these porphyrins were selective inhibitors of the VEGF/VEGFR PPI over the EGF/EGFR PPI. 45 Finally, the binding of porphyrins to lectins has been extensively studied 48 50,55 58 with crystal structures solved for H2TPPS binding to Jacalin (Fig. 4b) , 57 peanut lectin (PNA), 55 and concanavalin A. 59 
Resorcinarenes
Uchiyama and coworkers developed resorcinarene scaffolds for histone recognition. 60 63 They first developed compounds with 8 (monomeric) and 28 (tetrameric) (Fig. 5) peripheral carboxylates intended to match the basic surface of the histone. 60 This was followed by a more extended scaffold with 84 carboxylates. 61 These receptors were shown to be agglutinated by histone in a turbidity assay, and were shown to bind with Ka 4.2 × 10 5 M -1 , 1.3 × 10 7 M -1 , and 8.4 × 10 7 M -1 respectively by a kinetic analysis from a surface plasmon resonance (SPR) assay. Moreover the receptors were selective for histone over lysozyme and ovalbumin. 61 Subsequent studies adapted the system to (i) permit fluorescence based detection of binding, 62 (ii) establish binding to be electrostatically driven and (iii) exploit a mechanically interlocked rotaxane architecture for binding and FRET based histone detection. 63 In related studies, dipepetide substituted resorc [4] arenes have been exploited for binding to human serum H"A -chymotrypsin. 64 
Other scaffolds
The Hamilton group also investigated anthracene scaffolds as protein surface mimetics which bind to Cyt c Please do not adjust margins
Please do not adjust margins and lysozyme. 65 Similarly, bivalent cyclodextrins have been synthesised by Breslow and co-workers, to inhibit aggregation of citrate synthase and L-lactate dehydrogenase, by binding to (and thus preventing the aggregation of) surface exposed hydrophobic patches. 66 In related studies, Kano and Ishida developed a -cyclodextrin capable of binding to Cyt c. 67 This concept was further developed by formation of a ternary complex with a porphyrin spanning two Cyt c binding cyclodextrins. 67 
Dendrimers
Dendrimers are supramolecular scaffolds with high valency (Fig. 6) , possessing a central core that projects a branching network of repeating units culminating in terminal functionality which can be used for binding to proteins. 68 Protein recognition using dendrimers has recently been comprehensively reviewed by Marjorale et al.; 68 a few representative examples are highlighted here. Twyman and coworkers designed polyanionic poly(amidoamine) (PAMAM) dendrimers which bind to Cyt c and -chymotrypsin. 69, 70 PAMAM dendrimers have also been shown to bind to human serum albumin in an extensive study by the Giri group. 71 They studied binding constants, NMR ( 1 H, STD and DOSY) and molecular dynamic (MD) simulations of 19 PAMAM dendrimers in order to gain insight into the interactions, looking at differences in core, dendrimer generation and terminal group permitting detailed analyses of the key determinants of protein recognition. 
Metal-based scaffolds

Metal coordination to peptides and proteins
Metal-ligand interactions are stronger (in water) than the conventionally used protein recognition interactions such as hydrogen-bonding, electrostatics and van der Waals contacts. 72 This makes metal-ligand interactions a potentially useful tool for recognition of proteins, as fewer interactions might be needed for selective and high affinity binding. The scope of this approach is limited to those amino acids and post-translational modifications, which are able to coordinate to a metal centre. Naturally, one such coordinative interaction is already widely exploited in the purificat ion of proteins in the form of nickel or cobalt affinity chromatography which exploit the chelating ability of oligohistidine sequences. 73 75 Mallik and coworkers used this knowledge in an intelligent manner. They used molecules with copper(II)-iminodiacetate (IDA) arms (known histidine binding ligands) 76 to recognise patterns of surface-exposed histidine residues, resulting in recognition of bovine erythrocyte carbonic anhydrase (Fig. 7a) . 77, 78 A three Cu(II) system was used to bind three histidine side chains (Fig. 7a) on the N-terminus of the carbonic anhydrase, with the ligand alone showing no binding, highlighting the importance of the metal centre for recognition. The highest affinity compound (3 M Kd by isothermal titration calorimetry (ITC)) was also found to be selective for carbonic anhydrase over chicken egg albumin which has the same number of surface histidine residues (six) but positioned in a spatially distinct manner on the protein surface. Scaffolds for metal coordination to peptides and proteins , (a) Receptor for carbonic anhydrase that functions through recognition of histidine residues on the protein surface (inset: example of a carbonic anhydrase ligand making use of a Cu(IDA) motif to achieve histidine co-ordination, (PDB ID: 2FOV) 76 ; (b) Bis(Zn(II)dpa) receptor for recognition of phosphorylated peptides.
Please do not adjust margins
Please do not adjust margins to the use of the bis(Zn(II)Dpa) complexes in the binding of both mono-and multi-phosphorylated peptides via bidentate binding between the Zn(II) and the phosphate groups ( Fig.  7b) , resulting in conformational stabilisation. 81, 82 Recognition of phosphate groups on protein surfaces is significant given the role of protein phosphorylation in regulating signaling pathways. The bis(Zn(II)Dpa) receptors have been used as chemosensors by varying the bridging group between the two Zn(II) centres resulting in fluorescence changes on binding. 81 84 With doubly phosphorylate -helical peptides it was shown, by circular dichroism (CD), that with ) II -helical content of the peptide increases, and that that there is 10 -fold selectivity for doubly phosphorylated peptides over mono-phosphorylated peptides. 82, 85 This approach has subsequently been used to develop an inhibitor (IC50 = M the phosphoprotein-protein interaction between the phosphorylated CTD peptide and the Pin1 WW domain. 86 A more rigid diazastilbene linker was subsequently used in a receptor for doubly phosphorylated peptides. 87 More recently complexes based on these scaffolds have been linked to a bis[(4,6-diflurophenyl)pyridanto-N,C ] iridium(III) picolinate motif to generate a phosphorescent sensor for phosphorylated peptides with markedly improved selectivity over ATP. 88 Building on Hamachi G used bis(Cu(II)Dpa) and bis(Zn(II)Dpa) complexes to bind to phosphotyrosine on signal transduction and activator of transcription 3 (STAT3), thus inhibiting STAT3/STAT3 dimerisation. 89, 90 ITC and fluorescence polarisation (FP) data demonstrated the copper(II) complexes bound to a phosphopeptide (with micromolar Kd), thus inhibiting the phosphopeptide-protein complex, with micromolar Ki. 89 The copper(II) complexes were further shown to inhibit STAT3/STAT3:DNA binding in an electrophoretic mobility shift assay (EMSA) with IC50 = 8.2 M. They also exhibited low micromolar IC50s in 3 different cancer cell lines but much lower inhibition, and low cytotoxicity, in healthy NIH3T3 cells, thus highlighting their potential therapeutic utility. 89 Later, the same group illustrated the use of bis(Zn(II)Dpa) complexes as mimics of src homology domain 2 (SH2) domains; fluorescence quenching experiments demonstrated binding of these complexes to phosphotyrosine containing peptides, with Kd ~10 -7 M and some sequence identity discrimination. 90 Several of these compounds were also shown to be cytotoxic in three types of cancer cell. 90 Co-ordination complexes as ligands for protein surfaces Several surface mimetics use metals as a core structural unit, while the ligands surrounding the metal are used for protein binding. Using metals in a purely structural capacity, especially in thermodynamically or kinetically inert compounds, allows for their use in cellulo, as the metal is unable to non-specifically coordinate to biomacromolec ule s and exert a toxic effect.
Figure 8
Co-ordination complexes for kinase recognition (a) structures of different inhibitors highlighting similarity to natural product staurosporine a pan kinase inhibitor (b) X-ray crystal structure of a ruthenium complex bound to PAK1 kinase domain (PDB ID: 3FXZ) 103 
Metal complexes for kinase surface recognition
The use of metal co-ordination complexes as scaffolds has been pioneered by the Meggers group; they have focussed primarily on ruthenium(II) complexes, but more recently on rhodium(III), 91, 92 iridium(III), 93, 94 osmium(II) 95 and platinum(II) 96 coordination complexes. These have been used for inhibition of multiple protein kinases (Fig 8a) including Pim1, 97,98 glycogen synthase G"K 99 MSK1, 97 BRAF kinase, 100 and PAK1. 101 X-ray crystal structures have been solved for several of these compounds bound to their target protein kinase, demonstrating the metals act solely in a structural capacity (Fig. 8b) . 98, 102, 103 The majority of these coordination complexes function mechanistically as ATP 107 This approach has been informative in highlighting the utility of metal complexes for projecting recognition groups along vectors to gain additional non-covalent contacts with target proteins in a manner that is not possible using organic molecules.
Figure 9
Co-ordination complexes as TNF-R III complex TNFa) Dimer structure of TNF-(PDB ID: 2AZ5) highlighting hypothesized site of small molecule binding.
Group 9 metal complexes as PPI inhibitors
The Leung group have studied a series of iridium(III) and rhodium(III) co-ordination complexes with a view to identification of inhibitors of protein-protein interactions. 108 In an important proof of concept, cyclometalated iridium(III) complexes were shown to be capable of binding to tumour necrosis factor-TNF- (Fig. 9) . 109 The authors postulated that the complex utilises the aromatic bidentate ligands 2--biquinoline (biq), in order to target a hydrophobic binding site of the TNFdimer (Fig. 9b) , preventing active trimer formation. Both enantiomers of the complex were found, by ELISA, to have an IC50 M of SPD304, 110 one of the strongest inhibitors of TNFStructure activity relationships have since been performed, using 22 iridium(III) complexes with ligands of different shapes and sizes in order to generate low micromolar inhibitors (seen in an in cellulo inhibition of TNF-NF-B luciferase assay in HEP G2 cells). 111 They also looked at the effect of stereochemistry, comparing the isomers had increased cellular activity M M IC50 in the cellular assay) and binding affinity (30 M IC50 in an in vitro assay). 111 In a subsequent study the group synthesised iridium(III) and rhodium(III) compounds capable of binding to, and preventing dimerization and phosphorylation of the STAT3 (Fig. 10a) . 112 The most potent Rh(III) compound was found to have anti-tumour activity in a mouse xenograft tumour model and was found to bind to the SH2 domain of STAT3 with an IC50
M "TAT -down assays demonstrated inhibition of STAT3 dimerisation whilst Western blotting confirmed inhibition of STAT3 phosphorylation. The group have also screened a series of iridium complexes as inhibitors of the p53/hDM2 interaction (Fig. 10b) . 113 One compound was shown to be a 16 µM inhibitor in a fluorescence anisotropy competition assay. Subsequent cellular analysis confirmed the induction of p21 (a downstream target of p53) and apoptosis. The group have extended this strategy which is based only on molecular recognition between protein and metal complex to develop irreversible Ir(III) and Rh(III) Please do not adjust margins Please do not adjust margins inhibitors which also exploit co-ordinative interaction between the two. An Ir(III) based irreversible inhibitor of the interaction between bromodomain-containing protein 4 (BRD4) and acetylated histone peptide (Fig.  10c) has been developed. 114 The group initially screened 27 compounds and found a compound capable of modulating the interaction between BRD4 and chromatin in vitro and in vivo. The compound was found to bind to histidine residues, with the loss of acetonitrile ligands, and was found to be selective over the other histidine containing proteins STAT3 and caspase -6. The group have also developed Ir(III) and Rh(III) complexes A 1-40, 115 a peptide implicated in neurodegeneration A (Fig. 10d) . The authors proposed the compounds bind to histidine residues on the peptide, displacing the water ligands, and allowing further interactions of the hydrophobic ligands with hydrophobic residues at the Nterminus of the peptide. The compounds can also serve as luminescent probes for A 1-40. The use of metals to modify the properties of surface mimetics A number of conventional supramolecular scaffolds can be easily modified through the addition of a metal. Such compounds offer the advantage of fluorescence or phosphorescence, which may be exploited to detect binding without the need for peripheral functionalization as required for conventional small molecules. The metal may also modify the binding behaviour e.g. by providing an additional coordination site where one or more ligands on the surface mimetic are labile or by modulating the electrostatic surface proximal to the site of coordination. The following section outlines where this has been explored for porphyrin-derived protein surface mimetics.
Metalloporphyrins
Considerable effort in the 1980s and 90s was devoted to the study of electron transfer between both metallo and non-metallo anionic porphyrins and Cyt c. 116 123 Jameson et al. compared two types of these porphyrins: uroporphyrins (URO) and tetracarboxyporphyrin (4CP). 121 4CP was shown to have higher quenching rates, possibly due to a difference in Cyt c binding orientation for the two porphyrins, as evidenced by differences in the induced CD of the porphyrins on binding to Cyt c. The Rodgers group also used cationic metalloporphyrins as extrinsic probes t o study peptide aggregation by analysing photoinduced electron transfer from tyrosine or tryptophan residues in the protein to the metalloporphyrin. 124, 125 F F carboxyphenylporphyrin bound to Cyt c, selectively over acetylated Cyt c, with Kd in the region 0.05 M 5 M using a flavodoxin competition assay, 116 the Hamilton group developed higher affinity Cyt c ligands (Fig 11) . 46, 47 Tetraphenyl porphyrin scaffolds provide a large, flat, semi-rigid molecular surface of ~300 400 Å 2 which with anionic substituents on the periphery bind to Cyt c in a 1:1 stoichiometry. 46, 47 The compounds were found to be selective for Cyt c over the related proteins Cyt c551 (a protein with a similar function, shape and secondary structure to Cyt c but lacking surface lysines) and ferredoxin. 47 Crowley and coworkers later analysed sulfonato-porphyrins binding to Cyt c by 1 H, 15 N HSQC NMR, with the results backed up by docking studies. 126 Theses analyses pointed to a dynamic ensemble of energetically similar interactions with the porphyrin occupying several different patches on the surface. 126 Please do not adjust margins
Please do not adjust margins complementarity to be key to the denatur . It was hypothesized that the effect arose due to the porphyrin binding preferentially to the unfolded state of the protein. Critically, metal ions were subsequently shown to dramatically control the binding behaviour of the porphyrin towards Cyt c, in particular copper(II) porphyrins (Fig. 11b) . 128, 129 Metalloporphyrins tend to dimerise/ aggregate more readily in water when compared to their free base analogues (Fig. 11b) due to enhanced -stacking. 130, 131 The exception are the zinc(II) variants which prefer to adopt a five co-ordinate geometry with an axial water molecule, thus retarding dimer formation. Consequently, the copper(II) derivative of the originally identified Cyt c receptor was shown to have higher affinity for Cyt c with accurate Kd values not being able to be obtained without increasing the ionic strength.
The copper(II) derivatives bind in a 2:1 stoichiometry porphyrin:protein.
The copper(II) porphyrins were shown to denature Cyt c at room temperature and do so selectively over -lactalbumin, Bcl-xL, Cyt c551, myoglobin and RNAse A. This ability to bind preferentially to the unfolded state of the protein resulted in an acceleration of the rate of tryptic proteolysis. This was first shown to occur in the presence of stoichiometric quantities of porphyrin and then catalytically (0.1 equivalents). In contrast, the free base and zinc(II) pophyrins did not do this presumably arising due to the dimeric nature of the copper (II) variant and hence higher charge density. Subsequently, copper(II) porphyrins were shown to denature both myoglobin and haemoglobin, seen by a decrease in melting temperature, increased trypsin digestion and decrease in the -helical content by CD. 132 The Hamilton group subsequently employed families of functionalized porphyrins in a protein sensing array for protein detection, 133, 134 whilst zinc(II) and iron(III) metalloporphyrins have also been shown to multimerise Cyt c7 from Geobacter sulfureducens, lysozyme and Cyt c at high (millimolar) porphyrin and protein concentrations, 135 as observed by SAXS and rationalised by molecular dynamics (MD) simulations.
Metallodendrimers
Zinc(II) porphyrin-based dendrimers have also been developed, with the fluorescent metallopor phyrin-core being utilised for detection/ sensing. 136 These large multivalent nanoscale structures have been used to bind to Cyt c, with the Cyt c/dendrimer complex being more stable than the native Cyt c/Cyt b5 PPI as demonstrated by 20 % fluorescence recovery (of the dendrimer) on addition of 14 equivalents of Cyt b5 to the Cyt c/dendrimer complex. One of these original Zn(II)-porphyrin dendrimers, and subsequent generations, were subsequently shown to improve cell viability when cells were subjected to an apoptotic stimulus. 137 It has been hypothesised that the dendrimers trap Cyt c, preventing it from interacting with Apaf1 to form the apoptosome , thus inhibiting apoptosis.
M(bpy)3 scaffolds for multipoint surface recognition
In the 1950s and 60s Dwyer and coworkers showed that simple bipyridine (bpy) and phenanthroline (phen) ruthenium(II) complexes ellicit bacteriostatic and bacteriocidal activities and also inhibit tumour growth, thus highlighting the potential use of these complexes. 138, 139 In an early designed approach Sasaki et al. described a saccharide substituted Fe(II)(bpy)3 complex capable of binding to lectins, 140 thus introducing the idea of using metal tris-bipyridines to project recognition domains over a protein surface to make multivalent non-covalent contacts and achieve binding. 140 Fe(II)(bpy)3 complexes are relatively dynamic in aqueous solution, this allows for the use of dynamic combinatorial chemistry around the Fe(II) core. This has been used by the Sasaki and de Mendoza groups in order to generate lectin binding complexes. 141, 142 Sasaki and coworkers generated an Fe(II) complex with a mono GalNAc substituted bipyridine, which altered its stereochemical configuration in solution resulting in the enrichment of higher affinity compounds for various different lectins. 141 De Mendoza and co-workers used bipyridines functionalised with 3 different sugars complexed them to Fe(II) then incubated them with the mannose binding lectin, Concanavalin A (ConA), this resulted in enrichment of the mannose functionalised complex (detected by LCMS), as predicted. 142 Please do not adjust margins Please do not adjust margins While the labile nature of the Fe(II) core can be useful for the generation of high affinity protein receptors, the inert nature of the ruthenium(II) core is attractive as decomplexation will not occur in biological media in dilute solution. 143 Moreover, the ruthenium(II) core permits detection of binding events through the metal to ligand charge transfer (MLCT) luminescence.
Kaboyashi and coworkers, 143,144 generated a series of glycofunctionalised Fe(bpy)3 and Ru(bpy)3 compounds, showing that the ruthenium glycoclusters had high lectin affinity and increased luminescence on lectin binding. Similarly, the Seeberger group developed sugar functionalised Ru(bpy)3 complexes (Fig. 12 ) that bind to the mannose-binding lectins ConA and galanthus nivilis agglutinin (GNA). 145 A follow-on study used digital logic analysis to determine the best lectin binders for further study: this was achieved by assessing the increase in luminescence output of the Ru(II)glycodendrimers in the presence of different lectins. 146 The complexes with surface bound lectins have also been used as luminescent sensors for measuring monosaccharide and oligosaccharide concentrations, by using the displacement of the Ru(II)glycodendrimers from a lectin surface by the sugar. 147 In a different approach the same group used related scaffolds functionalised with adamantane units, to recruit mannose functionalised -cyclodextrin i strategy to achieve high affinity binding of ConA Kd = 0.14 M as determined by SPR. 148 Finally, the Okada group also used galactose functionalised Ru(bpy)3 complexes to bind to peanut agglutinin (PNA) and glucose functionalised Ru(bpy)3 complexes to bind to ConA (Kd = M , using fluorescence emission and fluorescence polarisation. 149 Electron transfer experiments between Cyt c and Ru(bpy)3 complexes (as well as Ru(phen)3, Os(bpy)3 and Os(phen)3 complexes) were initially reported by Cho in the 1980s. 150 Subsequently Hamachi developed carboxylate functionalised Ru(bpy)3 derivatives 1 (Fig.  13b ) that could bind to and photoreduce Cyt c, selectively over a series of less basic proteins (myoglobin, horseradish peroxidase and Cyt b562). 151 The compounds were observed to bind to Cyt c using an ultrafiltration binding assay with the compound with the highest number of carboxylic acids (18 COOH) being shown to bind an order of magnitude more tightly than an unfunctionalised Ru(bpy)3 complex. The Ru(bpy)3 (Fig. 13b) . The Wilson group developed both mono-6 (Fig. 13b ) and di-2 (Fig. 13a) substituted Ru(bpy)3 complexes, which were shown to bind Cyt c. 152, 153 Using a fluorescence quenching assay, the highest affinity complex 2c was shown to bind to Cyt c with Kd = 1.6 nM (5 mM sodium phosphate, pH 7.4). 152 As with H 46 negatively charged substituents (based on aspartic acid moieties) were shown to promote high affinity binding in fluorescence quenching assays. 152 Notably, negative cooperativity was observed with increasing numbers of carboxylates 152 (i.e. as the overall affinity increases, the affinity per carboxylate decreases) presumably reflecting the fact that the roughly spherical shape of the ruthenium complex would prevent all carboxylates from simultaneously engaging the protein surface.
In subsequent studies focused on the role of geometrical and stereochemcial isomers, the mer isomers of the 5 -monosubstituted complexes 6 showed ~10 fold better binding affinity compared to the fac isomers e.g. mer) versus 172 -fac) nM for Cyt c (5 mM sodium phosphate, pH 7.4). In contrast, the bound Cyt c with little difference in their affinities (25 vs 29 nM for the mer isomers). 153 Further analysis using a functional ascorbate reduction assay demonstrated that both the disubstituted and monosubstituted bipyridine complexes slow the rate of reduction of Cyt c, probably as a consequence of blocking the approach of the reducing agent to the solvent exposed haem group on the surface of Cyt c, which is surrounded by basic amino acid residues. 152 The absence of binding to 60 % acetylated Cyt c confirmed this charge complementarity to be key for binding. 152, 153 Further analyses of the complex 2c, in a manner similar H 128 revealed it lowered the melting temperature of Cyt c by 25 °C and show an increased rate of proteolytic degradation at room temperature in both stoichiometric and substoichiometric quantities of the complex. 154 A change in the binding with a change from a 1:1 binding to a 2:1 (protein:complex) stoichiometry was observed on increasing the temperature from 25 to 70 °C. This result in particular adds to the original conceptual observation from the Hamilton group, 128 in that it implies negative co-operative binding to the unfolded form of Cyt c is favoured.
In cellulo studies have also been performed with these complexes (Fig. 14) . Meaningful monosubstituted derivatives 6 was limited by their lower quantum yield, however the 4 2 exhibited 95% efficiency of transfection into HEK-293T M
155
The complexes appeared to be taken into cells by endocytosis and were shown to localise to the lysosome. In the case of the anionic derivatives, they were also shown to be noncytotoxic. 155
Figure 14
Cell localisation behaviour of compound 2c; (a) 2c (emits pink/red), antibody for LAMP1 (emits green) and propidium iodide (denotes nucleus in blue/purple) in fixed cells (b) 2c and lysotracker in living cells (antibody emits green and denotes lysosomes). Co-localisation is denoted by a dashed white circle Simultaneously Ohkanda and co-workers developed dendritic Ru(bpy)3 complexes 3-5 ( Fig. 13a ) that bind to -chymotrypsin in a mixed 1:1 and -chymotrypsin) stoichiometry (e.g. 3 Kd = 130 and 430 nM (5 mM phosphate, pH 7.4) for the first and second equilibrium step respectively. 156 These surface mimetics inhibited the enzyme by non-competitive inhibition. 156 They later synthesised homo and heteroleptic complexes 4 and 5 -chymotrypsin and Cyt c, with submicromolar afinity. 157 Molecular modelling indicated that three isophthalic arms interact -chymotrypsin, and four interact with Cyt c. 157 In cellulo studies also highlighted a capacity for these compounds to enter cells. 157 
Conclusions
The development of protein surface mimetics has emerged as a novel approach for the inhibition of protein-protein interactions in chemical biology. Within this group of supramolecular receptors, organometallic and coordination complexes offer unique advantages. These unique properties have been demonstrated through the development of protein-surface mimetics that achieve binding through direct coordinative interactions with surface exposed ligands, by exploiting the additional vectoral pres entation of functional groups in metal complexes to achieve binding, and, by using a metal complex to project binding groups across a large surface area resulting in multivalent contacts. Despite these successes, many challenges remain, in particular, to refine, using computational modelling as appropriate, the structural diversity and asymmetry of these types of complexes so that their recognition of protein-targets is highly specific and of higher affinity. Beyond this it will be necessary to apply these approaches to the development of selective ligands for a far greater range of protein targets, and finally, to demonstrate more extensively a biological effect in cellulo and in vivo.
